Results 281 to 290 of about 223,134 (358)
Iron Profile Variability in Hemodialysis Chronic Kidney Disease Patients. [PDF]
Ogolla CO +3 more
europepmc +1 more source
Differences in the protein fluorescence of the two iron(lI1)-binding sites of ovotransferrin [PDF]
Evans, RW
core
The upper panel illustrates the study design, including recruitment, randomisation, intervention and oral glucose tolerance tests (OGTTs) conducted 2 weeks before and after. The lower panel shows reductions in serum ferritin associated with lower 2‐h OGTT glucose and lower glucose area under the curve (AUC).
Diego Mora‐Gonzalez +6 more
wiley +1 more source
Targeting the apical domain of the transferrin receptor: Development of a new protein scaffold for cellular delivery. [PDF]
Veetil AA +5 more
europepmc +1 more source
Summary Girls and women with bleeding disorders (GWBD) comprise more than half of all registered patients with bleeding disorders in the UK National Haemophilia Database. The gynaecological care of GWBD, until recently, has not been prioritised despite high health burdens, where four of every five patients experience heavy menstrual bleeding (HMB).
Laura Knox +17 more
wiley +1 more source
Dietary intake, nutritional status, and health outcomes among vegan, vegetarian, and omnivorous Czech families. [PDF]
Heniková M +12 more
europepmc +1 more source
Cytochrome P450 1A1 influences obesity‐induced pulmonary hypertension
Background and Purpose The contribution of obesity to pulmonary arterial hypertension (PAH) pathophysiology remains poorly understood. Adipose tissue synthesises estrogens via cytochrome P450 (CYP) 19A1 (aromatase), whereas circulating estrogens are metabolised in the lung by CYP1A1.
Joshua P. Dignam +12 more
wiley +1 more source
Anemia Profile in Elite Israeli Olympic-Level Athletes-Is Screening Necessary? [PDF]
Abulafia O +4 more
europepmc +1 more source
This study aimed to evaluate transferrin receptor (TfR) expression in human esophageal squamous cell cancer (ESCC) specimens and investigate the correlation between TfR overexpression and clinicopathological characteristics. Furthermore, we explored the potential of targeting iron metabolism pathways as a novel therapeutic strategy for ESCC.
Naoki Ikenaga +16 more
wiley +1 more source

